AmerisourceBergen, DMS Pharmaceutical, and Cardinal Health Awarded Pharmaceutical Contracts Worth Over $5.9 Billion

AmerisourceBergen Drug Corp., Conshohocken, Pennsylvania (SPE2DX-25-D-1000 $5,649,602,820); DMS Pharmaceutical Group Inc.,** Parkridge, Illinois (SPE2DX-25-D-9000, $277,666,966); and Cardinal Health Inc., Dublin, Ohio (SPE2DX-25-D-8000, $16,564,367), have each been awarded a firm-fixed-price requirements contract under solicitation SPE2DX-24-R-0001 for pharmaceutical and pharmaceutical-related products. This was a competitive acquisition with four responses received. These are two-year six-month base contracts with three two-year six-month option periods. Locations of performance are inside and outside the continental United States, with a March 6, 2027, performance completion date. Using customers are Defense Health Agency, Defense Department, Navy, Coast Guard, designated providers, and federal civilian agencies. Type of appropriation is fiscal 2025 through 2027 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.